Cargando…

P15-19. Evaluating community engagement efforts in a large, multi-site, global HIV vaccine trials network

Detalles Bibliográficos
Autores principales:	Maggard, K, Broder, G, Maclachlan, E, None, A
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767716/ http://dx.doi.org/10.1186/1742-4690-6-S3-P220

Ejemplares similares

P15-23. Community engagement strategies in the Canadian HIV vaccine initiative
por: Milsom, P, et al.
Publicado: (2009)

P15-15. Advocates' perspectives on community engagement in the HVTN 505
por: Warren, M, et al.
Publicado: (2009)

Global Efforts against HIV Epidemic and HIV Vaccine Development
por: Tanuma, Junko
Publicado: (2014)

P15-27. Community involvement and ethics in HIV vaccine trial in Nigeria
por: Adeyemi, AO, et al.
Publicado: (2009)

P14-11. Educating community medical providers about HIV vaccine induced seropositivity
por: Mark, KE, et al.
Publicado: (2009)

P15-17. Social media as a tool for engaging and educating audiences around HIV vaccine research and clinical trial participation
por: Sitar, S, et al.
Publicado: (2009)

P15-03. HIV vaccine funding trends entering a global recession: research and development (R&D) from 2000 – 2008
por: Fisher, K, et al.
Publicado: (2009)

P15-09. The potential global market size and public health value of hypothetical HIV-1 preventive vaccines with different levels of efficacy
por: Marzetta, CA, et al.
Publicado: (2009)

P15-25. Preparation for HIV vaccine trials in Africa: barriers and facilitators for the establishment of a community advisory board in Burkina Faso
por: Berthe, A, et al.
Publicado: (2009)

A novel HIV vaccine targets the 12 protease cleavage sites
por: Luo, M, et al.
Publicado: (2012)

P15-26. Leveraging motivators to participation in HIV vaccine research in the age of Obama
por: Alexander, SB, et al.
Publicado: (2009)

Cost-effectiveness of atazanavir-ritonavir versus lopinavir-ritonavir in HIV patients initiating first-line antiretroviral therapy
por: Broder, MS, et al.
Publicado: (2010)

P15-11. Preventive HIV vaccine acceptability: a systematic review and meta-analysis
por: Newman, PA, et al.
Publicado: (2009)

P15-18. Behavioral and social science in HIV vaccine clinical research: workshop recommendations
por: Lau, C, et al.
Publicado: (2009)

P15-20. Developing a national policy agenda for the Canadian HIV vaccine initiative
por: Sarazin, V, et al.
Publicado: (2009)

P15-22. Potential synergies between HIV vaccines, microbicides and pre-exposure prophylaxis
por: Sarazin, V, et al.
Publicado: (2009)

Effort-reward imbalance among medical students and physicians
por: Jerg-Bretzke, Lucia, et al.
Publicado: (2014)

Pressure reconstruction method for spontaneous breathing effort monitoring
por: Damanhuri, N, et al.
Publicado: (2015)

P15-28. Attitudes and awareness of HIV vaccine research in HIV uninfected MSM in four US cities: Rochester, Boston, San Francisco and Philadelphia
por: Alexander, SB, et al.
Publicado: (2009)

Using the media social Facebook to increase the community voluntarism and engagement to monitoring ARV in Indonesia
por: Widjaja, Irwandy, et al.
Publicado: (2014)

P15-01. Willingness to participate in actual preventive HIV vaccine phase I/IIa trial in Bangkok, Thailand
por: Hemachandra, A, et al.
Publicado: (2009)

Willingness to participate in HIV vaccine efficacy trials in a population of fishing communities, Uganda
por: Nanvubya, A, et al.
Publicado: (2012)

P15-12. Community advisory boards' successes and challenges in AIDS vaccine clinical trials: a Southern Africa experience
por: Mokhele, T
Publicado: (2009)

Vaccine-induced tumor regression requires a multi-step cooperation between T cells and myeloid cells at the tumor site
por: Thoreau, Maxime, et al.
Publicado: (2015)

Capnometry successfully predicts outcome and determination of the cessation of cardiopulmonary resuscitation efforts
por: Hajdinjak, EH, et al.
Publicado: (2012)

Brain ventricle volume correlates with effortful control in healthy young males
por: Tang, Rongxiang, et al.
Publicado: (2012)

Rejection for ICU admission: analysis and results of this modality of limitation of therapeutic effort
por: Acosta, F, et al.
Publicado: (2015)

Reference values for regional and global myocardial T2 mapping with cardiovascular magnetic resonance at 1.5T and 3T
por: Maceira, Alicia M, et al.
Publicado: (2015)

Evaluating short-term patient outcomes after HIV care interventions in a low resource setting: preparing for an HIV vaccine trial site in Bamako, Mali
por: Koty, Z, et al.
Publicado: (2012)

The recognition of HIV-1 consensus group M Gag and Nef peptide reagents in mono- and multi-clade epidemics: implications for HIV vaccine design
por: Zembe, L, et al.
Publicado: (2012)

HIV patients admitted to an ICU of a university hospital - experience of 15 years: 1995 to 2009
por: Agrifoglio, A, et al.
Publicado: (2013)

Extracorporeal membrane oxygenation before and after adult liver transplantation: worth the effort?
por: Auzinger, G, et al.
Publicado: (2014)

Effect of different pressure-targeted modes of ventilation on transpulmonary pressure and inspiratory effort
por: Rittayamai, N, et al.
Publicado: (2015)

P15-05. Evaluation and recommendations on good clinical laboratory practice (GCLP) guidelines for phase I-III HIV vaccine clinical trials
por: Sarzotti-Kelsoe, M, et al.
Publicado: (2009)

P15-30 LB. An evaluation of prescreen recruitment data: enrolling racial/ethnic minorities in Phase I HIV vaccine clinical trials
por: Johnson, D, et al.
Publicado: (2009)

Difficulties in controlling HIV and TB infections in multi-experienced patients
por: Benea, Șerban, et al.
Publicado: (2014)

Service integration of blood borne viral infections in HIV/AIDS prevention sites
por: McCadney, Steven
Publicado: (2010)

Antigen processing sites in gp120 are conserved across HIV virus clades
por: Yu, B, et al.
Publicado: (2012)

The RNA structure of the major splice donor site controls HIV-1 splicing
por: Mueller, Nancy, et al.
Publicado: (2013)

Why are all multi-centre trial sites not the same? A network analytic approach
por: McAneney, Helen
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qcma90mk5a9mjn2iu6m1482m7n